Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV.
Phase of Trial: Phase IV
Latest Information Update: 10 Apr 2013
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 09 Sep 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 09 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Oct 2009 New trial record